GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

NCT07083154 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Dementia, Mild
Mild Cognitive Impairment
Type 2 Diabetes

Interventions

DRUG: Mazdutide
DRUG: Placebo

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]